76 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anticoagulants"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
2 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
3 Not yet recruiting Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events
Conditions: Incidence of Readmissions;   ADE's Due to Anticoagulants
Intervention:
4 Recruiting Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
Conditions: Aortic Valve Disease;   Heart Valve Prosthesis Implantation;   Anticoagulants
Intervention: Drug: Rivaroxaban
5 Unknown  Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
Conditions: Deep Vein Thrombosis;   Enoxaparin;   Anticoagulants
Intervention: Drug: Enoxaparin
6 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
7 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
8 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
9 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
10 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
11 Recruiting Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
12 Recruiting Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
13 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
14 Recruiting Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Condition: No High Risk of Hemorrhage
Intervention: Device: Intermittent pneumatic compression of the lower limbs
15 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
16 Not yet recruiting A Clinical Study of Lyophilized Plasma in Patients on Warfarin
Condition: Anticoagulant Therapy
Interventions: Biological: Lyophilized Plasma;   Biological: Licensed Plasma
17 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
18 Unknown  Determination of Residual Anticoagulatory Effects of Fondaparinux
Condition: Anticoagulant Prophylaxis/Therapy
Intervention:
19 Recruiting Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
20 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years